Jeffrey V. Ravetch, Director at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), sold 131,500 shares at $0.60 ($79K) on 2016-03-24, disclosed to the SEC on 2016-03-25.
Open-market sale of $79k MBVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.